Live AusBiotech updates | Page 12

Live AusBiotech news coverage of developments with the latest updates. Stay on top of latest AusBiotech news stories and find out what just happened, what is going on with AusBiotech. The latest real-time news updates and headlines on AusBiotech
First subjects randomised and dosed in Paradigm's late-stage trial
Adherium releases next generation respiratory platform integration services
Opthea announces appointment of two new directors
New UK-based business development for Adherium
NSW Government seeks operator for RNA manufacturing
Medlab Clinical confirms northern hemisphere distribution
Volpara Health announces leadership and board changes
Mission to BioKorea to strengthen ties
EpiAxis Therapeutics appoints new chief science officer
Zelria Therapeutics executes acquisition of Health House
Botanix confirms presentation of data at upcoming congress
Imugene says first cohort two patient dose in phase 1 clinical trial
Microbio is step closer to launching its InfectID-BSI tests in Europe
Rhonomed completes institutional component of capital raise
Australian Pavilion returns in-person to BIO 2022
MTPConnect announces support for major new resilience projects
Race receives human ethics approval for new trial
Microba announces new research partnership and senior appointment
Australian healthcare investor urges greater support from peers
Avecho reports positive results for Phase 2 topical CBD osteoarthritis study
NTCELL to be produced in Australia under UTS research agreement
Government launches biotechnology - strategic plan for health and medicine
Dimerix receives R&D tax rebate for last financial year
Neuren receives FDA approval for Pitt Hopkins IND and Phase 2 trial
BioScience Managers welcomes FDA approval of Saluda technology
Large molecule facility doubles size of leading bioanalytical laboratory
Industry concerned by leaked Covid vaccine IP waiver text
Biotron updates on pre-clinical study of BIT225 in Covid
US FDA grants new orphan designation to Noxopharm's Veyonda
Access savings by registering early for AusMedtech 2022
Australia and Korea sign MoU on vaccine research
Paradigm secures UK approvals for PARA_OA_002 clinical trial
First Participants dosed in ENA Respiratory's phase 2a study
WA funding programmes open
Neuren receives ethics approval for Angelman Phase 2 trial
'Gold standard' commercialisation for biotech
Partnership encourages innovation in how universities and industry collaborate
Partnership encourages innovation in how Australian universities and industry collaborate
Telix's ZIRCON late-stage kidney cancer imaging study completes enrolment
Rebrand for Australia's largest life sciences venture fund
Victoria's Medtech Manufacturing Capability Programme opens
Recognition for Vetter in CMO Leadership Awards
Chimeric Therapeutics announces final results from Phase 1 trial of CORE NK Platform
International Women's Day: AusBiotech 'moving dial' on gender equity
Antisense Therapeutics confirms ATL1102 poster presentation
New expedited regulatory pathway proposed for novel biologicals
Approval for Neuren Pharmaceuticals' Phase 2 trial in Angelman syndrome
Patrys selects stable cell line for production of PAT-DX3